NEW YORK (360Dx) – Novogene said that its next-generation sequencing medical lab in Tianjin, China, has received accreditation from the College of American Pathologists enabling it to provide clinical sequencing services to customers worldwide.

The firm noted that it recently launched the first NGS tumor gene-detection kit cleared by the China Food and Drug Administration.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.